We are live on ! Find out more
PODD icon

Insulet

423 hedge funds and large institutions have $13.3B invested in Insulet in 2020 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 181 increasing their positions, 120 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 36

51% more repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 120

21% more capital invested

Capital invested by funds: $11B → $13.3B (+$2.3B)

9% more funds holding

Funds holding: 387423 (+36)

1.48% less ownership

Funds ownership: 105.32%103.84% (-1.5%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

19% less call options, than puts

Call options by funds: $33.3M | Put options by funds: $41M

Holders
423
Holders Change
+36
Holders Change %
+9.3%
% of All Funds
8.65%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.1%
New
74
Increased
181
Reduced
120
Closed
36
Calls
$33.3M
Puts
$41M
Net Calls
-$7.73M
Net Calls Change
-$11.5M

PODD Hedge Fund Activity: Q2 2020 in Review

423 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2020, worth a combined $13.3B — up 21% from $11B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new PODD positions and 36 closed out — a net gain of 38 holders — while 181 added to existing stakes and 120 trimmed.

The largest buyer was Capital World Investors, adding an estimated $180M. The largest seller was Capital Research Global Investors, cutting an estimated $209M.

  • 423 institutional investors held Insulet (PODD) as of Q2 2020, up from 387 in Q1 2020.
  • Funds reported $13.3B of Insulet stock for Q2 2020, up 21% quarter-over-quarter.
  • 74 funds opened new Insulet positions in Q2 2020 and 36 closed out, a net change of +38 holders.
  • The largest Insulet buyer in Q2 2020 was Capital World Investors, an estimated $180M added.
  • The largest Insulet seller in Q2 2020 was Capital Research Global Investors, an estimated $209M sold.

Based on aggregated 13F filings for Q2 2020.